Cannula Market (2026 - 2033)

Cannula Market Summary

The global cannula market was valued at USD 2.1 billion in 2025 and is projected to grow from USD 2.2 billion in 2026 to USD 3.7 billion in 2033, at a CAGR of 7.6% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 41.0% in 2025. The increase in demand for minimally invasive surgeries, the rise in the number of surgeries among the geriatric population, and the significant increase in the prevalence of chronic lifestyle-related diseases such as diabetes and cardiovascular diseases are the primary factors that are driving market growth.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Supportive government initiatives to provide primary healthcare services at affordable rates and increase awareness regarding chronic diseases are anticipated to further help the market grow significantly during the forecast period. The increase in healthcare spending by many countries, along with government efforts to provide affordable healthcare and raise awareness, is anticipated to drive the market further. For instance, in December 2025, NIH report says that Cannula is safer than needle in filler injections. Further cannulas are also labeled as risk-free, safe and efficient to patients.

The increasing demand for cannulas is being met by a rising number of manufacturers and suppliers across the globe. These market leaders, with their extensive distribution networks, make technologically advanced products readily available worldwide. The evolution of nasal cannulas, such as the use of silicone material, extra soft and latex-free designs, curved and flared cannulas, has greatly enhanced comfort and flexibility. For instance, Intersurgical’s i-flo cannula is a single-use patient interface developed to supply High-Flow Oxygen Therapy (HFOT). HFOT has evolved into a critical respiratory aid for patients with hypoxemic respiratory failure and offers several advantages over traditional oxygen therapy.

Minimally invasive surgeries are gaining popularity in the healthcare industry. There has been a rapid increase in the preference for minimally invasive surgeries for the treatment of cardiovascular diseases. This is because minimally invasive surgeries cause less surgical trauma and result in a better aesthetic appearance. It offers advantages such as smaller incisions, reduced infection risk, smaller scars, less bleeding, and less pain & trauma. Thus, this is leading to an increased preference for minimally invasive surgeries, which in turn is expected to boost the market growth. Cannulas are increasingly used for hyaluronic acid fillers as they may improve patient comfort and tolerability.

Analyst Perspective

The cannula market is set for sustained growth, driven by favorable government initiatives, rising healthcare expenditure, and expanding global distribution networks. Increasing awareness of chronic diseases and broader access to affordable care are significantly boosting procedural volumes worldwide. Furthermore, growing clinical evidence highlighting safety advantages over traditional needles is accelerating adoption in aesthetic filler procedures. High demand for minimally invasive treatments across cardiovascular, respiratory, and cosmetic applications continues to drive the need for specialized precision cannulas. To meet this demand, manufacturers are focusing on innovations such as soft silicone, latex-free, and high-flow oxygen models to improve comfort and clinical outcomes. Together, these factors are enhancing product accessibility and strengthening market penetration across diverse healthcare settings.

Product Insights

The cardiac segment led the market with the largest revenue share of approximately 46.5% in 2025. The market is segmented into cardiac (arterial, venous, cardioplegia, and others), dermatology, nasal, and others. The growth of the cardiac segment is attributed to the high prevalence of cardiovascular diseases. Increasing shift towards a sedentary lifestyle, consumption of processed foods, and reduced amounts of physical activity are leading to a rise in the prevalence of cardiovascular disease. In May 2024, the CDC reported that heart disease remains the leading cause of death in the U.S., claiming one life every 33 seconds due to cardiovascular disease. In addition, the increase in the geriatric population that is higher risk of developing these diseases is also contributing to a significant rise in cardiovascular diseases.

The dermatology segment is expected to grow at the fastest CAGR during the forecast period. This is due to the increasing use of micro-cannula to avoid complications during and after procedures. Moreover, there is a significant rise in the number of cosmetic surgeries being carried out, which is anticipated to further boost the demand for the dermatology segment. In June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS) released its annual Global Survey, showing a 5.5% increase in surgical procedures, with 15.8 million surgical and 19.1 million non-surgical procedures. The overall increase over four years is 40%.

End Use Insights

The hospitals segment led the market with the largest revenue share of over 53.0% in 2025. This is due to the rise in hospitalization rates for a variety of causes and associated treatments. Cannulas are used in a wide variety of specialty departments in the hospitals, including orthopedic surgery, cardiovascular surgery, neurology, gynecology, general surgery, oxygen therapy, dermatology, and many more. According to AAFA statistics from April 2024, approximately 27.0 million Americans, or about 1 in 12 individuals, live with asthma.

The ambulatory surgical centers segment is expected to witness the fastest CAGR over the forecast period. Ambulatory surgical centers are modern healthcare facilities that offer same-day surgical care, along with preventive and diagnosis procedures. Thus, there is a rise in the shift towards ambulatory surgical centers for treatment and to avoid hospitalization. This, in turn, is leading to a rise in the number of ambulatory surgical centers. Currently, there are more than 9,280 active ambulatory surgical centers in the U.S.

Type Insights

The straight cannula segment led the market with the largest revenue share of approximately 35.5% in 2025. The market is fragmented into neonatal, straight, winged, a wing with port, and winged with stop cork cannula. A straight cannula is due to its design, which makes it simpler to use. The product’s extra-sharp needle makes it easier to insert as well. Therefore, these types of cannula are used in cardiac surgeries to avoid mishaps and reduce unnecessary delays that may prolong the entire process. For instance, Boston Scientific provides RF Cannula, developed for significant manufacturers’ electrodes. All straight cannula are available in various sizes, color-coded to correspond to the related electrode, and consistent with all Boston Scientific RF Electrodes of matching measurement.

The winged cannula segment is expected to grow at a rapid CAGR over the forecast period. The winged cannula segment is driven by its user-friendly design and increasing adoption of modern cannulas with improved features. Winged cannula are preferred for their ease of use and reduced risk of complications during insertion. For instance, GBUK Group Ltd. provides a safety-winged infusion set with a small Japanese steel needle for smooth atraumatic insertion. The shield smoothly glides over the needle until it securely seals into a fast system, deterring needle-stick harm.

Material Insights

The plastic segment led the market with the largest revenue share of approximately 57.0% in 2025, due to its increased adoption rate in both in-patient and out-patient procedures. Most plastic cannulas are translucent and allow surgeons to visualize instrumentation & sutures passing through the cannula in shoulder arthroscopy. Thus, making it suitable for using it maximum procedures, which are leading to its dominance throughout the forecast period. In April 2024, Produits Dentaire SA (PD-Dental) introduced a flexible plastic cannula to replace metal irrigation cannulas in root canal surgery, citing improved safety and effectiveness in navigating complex root canal curves and enabling more complete irrigation.

The silicone segment is expected to witness at the fastest CAGR over the forecast period. This is attributed to the increasing use of silicone cannulas in oxygen therapy, to ensure a continuous supply of oxygen to patients during surgery and to people suffering from respiratory disorders. Moreover, silicone cannulas are soft and flexible, which makes them a preferred choice for application among healthcare professionals and patients. For instance, Med Europe s.r.l.'s True Flow RDB cannula features two lumens: the main lumen for brain blood infusion via the innominate and left carotid arteries, and a second lumen for the positioning balloon near the tip.

Size Insights

The 18G size segment led the market with the largest revenue share of approximately 29.0% in 2025, owing to the 18G size cannula being widely used in hospitals for adults as well as adolescents. 18G cannulas are used to infuse blood products and deliver medications. These cannulas aim for a quick blood transfusion. They are used for computed tomography/pulmonary embolism protocols or other testing that needs large IV sizes.

The 22G segment is projected to grow at the fastest CAGR from 2026 to 2033. This can be attributed to its small gauge size, which allows a faster flow of fluid in patients with complicated veins. Mostly, nursing students prefer a 22G cannula for adult patients as it is designed to minimize needlestick injuries.

Regional Insights

North America dominated the cannula market with the revenue share of approximately 41.0% in 2025, owing to the availability of advanced healthcare facilities in the region and the presence of dominant market players. In addition, the increasing prevalence of lifestyle diseases in the region is a major factor in its dominance. Other factors such as greater awareness about minimally invasive surgeries and the increasing adoption rate of cosmetic surgeries in this region are further driving the growth in this region. According to the plastic surgery statistics report of 2024 by American Society of Plastic Surgeons (ASPS), demand for plastic surgery remains steady.

To learn more about this report, Download Free Sample Report

U.S. Cannula Market Trends

The cannula market in the U.S. is projected to grow at the fastest CAGR during the forecast period. In the U.S. market, the increasing demand for minimally invasive procedures across various medical specialties is a significant trend. This trend is driven by technological advancements in cannula design, which allow for more precise and less invasive procedures, leading to reduced patient recovery times and healthcare costs. The rising prevalence of chronic diseases such as cardiovascular diseases and cancer is fueling the adoption of cannulas for diagnostic and therapeutic purposes. The market is also witnessing a shift towards disposable cannulas due to infection control and patient safety concerns. New innovative devices are launched regarding patient safety. For instance, in June 2026, CyndRx, announced FDA approval for AbsorbaSeal vascular closure device. These devices are designed to reduce complexity, provide patient-friendly solutions to avoid use of collagen-based implants.

Europe Cannula Market Trends

The cannula market in Europe is recognized as a lucrative region owing to the growing emphasis on R&D activities to introduce innovative products with enhanced features. Companies focus on developing cannulas with improved materials, designs, and functionalities to cater to the evolving needs of healthcare professionals and patients. Regulatory initiatives promoting single-use medical devices influence market dynamics in Europe, leading to a higher adoption rate of disposable cannulas.

The UK cannula market is expected to grow at a significant CAGR over the forecast period. There is a growing trend towards value-based healthcare in UK which prompts healthcare providers to seek cost-effective solutions such as reusable cannulas that offer long-term durability and performance benefits. The National Health Service (NHS) is crucial in shaping procurement practices for medical devices such as cannulas in the UK market.

The cannula market in France is anticipated to grow at the fastest CAGR over the forecast period. In France, the market is witnessing a growing trend towards adopting minimally invasive procedures, increasing the demand for cannulas. The market is influenced by a rising prevalence of chronic diseases and an aging population, leading to a higher demand for surgical interventions where cannulas are used. There is a focus on technological advancements in cannula design to improve patient outcomes and reduce procedure times. French regulations emphasizing patient safety and quality standards play a significant role in shaping the market landscape.

The Germany cannula market is expected to grow at a substantial CAGR over the forecast period. With a strong presence of local manufacturers known for their high-quality, precision-engineered medical devices, the market in Germany is expected to grow faster. German companies are renowned for their adherence to strict quality standards and compliance with regulatory requirements, positioning them as key players in the global market. An increasing focus on sustainability and environmental responsibility is leading to a preference for eco-friendly materials in cannula production. This emphasis on sustainability aligns with consumer preferences for green products and drives innovation in biodegradable or recyclable cannula materials.

Asia Pacific Cannula Market Trends

The cannula market in Asia Pacific is expected to witness at the fastest CAGR from 2026 to 2033. Growth in this region is driven by a drastic rise in the geriatric population which creates a massive patient pool with individuals suffering from chronic diseases such as cardiovascular diseases and diabetes. In September 2025, according to WHO, heart diseases are leading cause of death in South-East Asia, claiming lives of eight people every minute. The increasing efforts by the government to introduce favorable policies to transform the healthcare sector, especially in the rural areas, are further expected to boost the market growth in this region.

The China cannula market is expected to grow at the fastest CAGR over the forecast period. The market in China is experiencing rapid growth driven by increasing healthcare expenditure, a growing elderly population, and rising awareness about minimally invasive procedures. In China, the government’s initiatives to improve healthcare infrastructure and provide better access to healthcare services in rural areas. This has led to an expansion of healthcare facilities and an increase in surgical procedures using cannulas across different regions in China.

The cannula market in Japan is anticipated to grow at a significant CAGR over the forecast period. In Japan, the market is characterized by a strong emphasis on precision engineering and high-quality medical devices. Japanese consumers prioritize safety, reliability, and efficiency in medical products such as cannulas. This focus on quality has led to stringent regulatory standards governing medical device manufacturing and distribution, including cannulas. The market is also influenced by a growing demand for cosmetic surgeries and aesthetic procedures, driving the adoption of specialized cannulas designed for such applications.

The India cannula market is anticipated to grow at a rapid CAGR over the forecast period. The market in India is witnessing significant growth due to increasing disposable income, expanding healthcare infrastructure, and a rising burden of chronic diseases requiring surgical interventions. The prevalence of medical tourism, with India emerging as a hub for affordable healthcare services, is a significant trend attracting patients worldwide. This created opportunities for domestic and international manufacturers to cater to diverse patient needs through a wide range of cannula products.

Middle East & Africa Cannula Market Trends

The cannula market in Middle East and Africa is projected to grow at the fastest CAGR during the forecast period. In the Middle East and Africa region, the market is witnessing significant growth driven by increasing healthcare expenditure, rising prevalence of chronic diseases, and advancements in medical technology. There is a growing adoption of minimally invasive procedures, which has led to a higher demand for cannulas across various medical specialties. The increasing focus on improving healthcare infrastructure and access to quality medical services also expands the Middle East and Africa cannula market.

The Saudi Arabia cannula market is expected to grow at a rapid CAGR over the forecast period. Saudi Arabia’s market is experiencing notable growth due to a rapidly growing population, government initiatives to enhance healthcare services, and a rise in lifestyle-related diseases. The increasing investment in R&D activities related to medical devices, including cannulas. This emphasis on innovation is driving the introduction of advanced cannula products tailored to meet the specific needs of healthcare providers and patients in the country.

The cannula market in Kuwait is anticipated to witness at a significant CAGR over the forecast period. In Kuwait, the market is witnessing steady growth propelled by factors such as a growing senior population, increased surgical procedures, and a focus on expanding healthcare facilities. A distinctive factor impacting the market in Kuwait is the emphasis on medical tourism, with the country positioning itself as a hub for advanced healthcare services in the region. This focus on attracting international patients for complex medical treatments drives the demand for high-quality medical devices like cannulas in Kuwait.

Key Cannula Company Insights

Key players operating in the global market are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are playing a key role in propelling the market growth.

Key Cannula Companies

The following key companies have been profiled for this study on the cannula market:

• Medtronic

• Becton Dickinson (BD)

• Edward Lifesciences

• LivaNovaca

• Smiths Medical

• Boston Scientific Corporation

Recent Developments

• In July 2025, LivaNova received U.S. FDA 510(k) clearance for its RAP Femoral Venous Cannulae. This cannula was developed for cardiopulmonary bypass procedures.

• In February 2025, ClearPoint Neuro, Inc. received European Medical Device Regulation (EU MDR) approval for the SmartFlow Neuro Cannula. This certification extended the shelf life of the SmartFlow Cannula for 48 months in the European Union (EU).

Global Cannula Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global cannula market report based on product, type, size, material, end use, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Cardiac

    • Arterial

    • Venous

    • Cardioplegia

    • Femoral

  • Dermatology

  • Nasal

  • Others

• Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Neonatal cannula

  • Straight cannula

  • Winged cannula

  • Wing with Port

  • Winged with Stop Cork

• Material Outlook (Revenue, USD Billion, 2021 - 2033)

  • Plastic

  • Metal

  • Silicone

• Size Outlook (Revenue, USD Billion, 2021 - 2033)

  • 14G

  • 16G

  • 18G

  • 20G

  • 22G

  • 24G

  • 26G

• End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hospital

  • Ambulatory Surgical Centers

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait